Filip Dubovsky, Chief Medical Officer, Novavax said, “All vaccines that are being distributed globally commercially are being made in a single facility by our partners (the Serum Institute in India) that includes the vaccines which are being deployed around the world as well as the ones that will be initially deployed in the U.S.”
Novavax has recently announced that its COVID-19 vaccine initially available in the United States, if authorised, will be manufactured by the Serum Institute of India.
Filip Dubovsky, Chief Medical Officer, Novavax said, “All vaccines that are being distributed globally commercially are being made in a single facility by our partners (the Serum Institute in India) that includes the vaccines which are being deployed around the world as well as the ones that will be initially deployed in the U.S.”
- Advertisement -